3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Carcinoma, Non-Small-Cell Lung
26
Breast Neoplasms
25
Lung Neoplasms
24
Colonic Neoplasms
18
Head and Neck Neoplasms
16
Rectal Neoplasms
14
Sarcoma
10
Prostatic Neoplasms
10
Neoplasm Metastasis
9
Pancreatic Neoplasms
8
Neoplasms
7
Mouth Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Ovarian Neoplasms
6
Glioblastoma
6
Adenomatous Polyposis Coli
6
Precancerous Conditions
5
Neuroblastoma
5
Liver Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Oropharyngeal Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Interventions
Pancreaticojejunostomy
4
Octreotide
2
obeticholic acid
1
fludarabine
1
apixaban
1
aldesleukin
1
X-Rays
1
Ursodeoxycholic Acid
1
Tranexamic Acid
1
Tissue Adhesives
1
Tea
1
Surgical Procedures, Operative
1
Stents
1
Specimen Handling
1
Sodium Chloride
1
Rivaroxaban
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Pantoprazole
1
Nutritional Status
1
Nutrition Therapy
1
Irinotecan
1
Iopamidol
1
Hydromorphone
1
Hydrocortisone
1
High-Energy Shock Waves
1
Epinephrine
1
Enteral Nutrition
1
Endoscopy, Gastrointestinal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Duodenal Neoplasms
×
Celecoxib
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled